{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:05:17Z","timestamp":1791255917531,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10637-024-01455-x","type":"journal-article","created":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T09:02:12Z","timestamp":1723971732000},"page":"518-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design optimization of Fucoidan-coating Cationic Liposomes for enhance Gemcitabine delivery"],"prefix":"10.1007","volume":"42","author":[{"given":"Epiphane K.","family":"Silli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,18]]},"reference":[{"key":"1455_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: Changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 164:752\u2013765. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.012","journal-title":"Gastroenterology"},{"key":"1455_CR2","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"J-X Hu","year":"2021","unstructured":"Hu J-X, Zhao C-F, Chen W-B et al (2021) Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol 27:4298\u20134321. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4298","journal-title":"World J Gastroenterol"},{"key":"1455_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM (2022) Pancreatic cancer: Pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163:386-402.e1. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056","journal-title":"Gastroenterology"},{"key":"1455_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.21147\/j.issn.1000-9604.2020.06.04","volume":"32","author":"W Luo","year":"2020","unstructured":"Luo W, Tao J, Zheng L, Zhang T (2020) Current epidemiology of pancreatic cancer: Challenges and opportunities. Chin J Cancer Res 32:705","journal-title":"Chin J Cancer Res"},{"key":"1455_CR5","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.21873\/anticanres.13026","volume":"38","author":"M Aslan","year":"2018","unstructured":"Aslan M, Shahbazi R, Ulubayram K, Ozpolat B (2018) Targeted therapies for pancreatic cancer and hurdles ahead. Anticancer Res 38:6591\u20136606. https:\/\/doi.org\/10.21873\/anticanres.13026","journal-title":"Anticancer Res"},{"key":"1455_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","volume":"12","author":"P Sarantis","year":"2020","unstructured":"Sarantis P, Koustas E, Papadimitropoulou A et al (2020) Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 12:173\u2013181. https:\/\/doi.org\/10.4251\/wjgo.v12.i2.173","journal-title":"World J Gastrointest Oncol"},{"key":"1455_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/pharmaceutics11110574","volume":"11","author":"K Samanta","year":"2019","unstructured":"Samanta K, Setua S, Kumari S et al (2019) Gemcitabine combination nano therapies for pancreatic cancer. Pharmaceutics 11:574. https:\/\/doi.org\/10.3390\/pharmaceutics11110574","journal-title":"Pharmaceutics"},{"key":"1455_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2023.11.028","volume":"365","author":"X Wang","year":"2024","unstructured":"Wang X, Lu H, Luo F et al (2024) Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. J Controlled Release 365:112\u2013131. https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.028","journal-title":"J Controlled Release"},{"key":"1455_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","volume":"741","author":"CL de Sousa","year":"2014","unstructured":"de Sousa CL, Monteiro G (2014) Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. Eur J Pharmacol 741:8\u201316. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.041","journal-title":"Eur J Pharmacol"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/cancers9110157","volume":"9","author":"M Amrutkar","year":"2017","unstructured":"Amrutkar M, Gladhaug IP (2017) Pancreatic cancer chemoresistance to gemcitabine. Cancers 9:157. https:\/\/doi.org\/10.3390\/cancers9110157","journal-title":"Cancers"},{"key":"1455_CR11","doi-asserted-by":"publisher","first-page":"1111991","DOI":"10.3389\/fphar.2023.1111991","volume":"14","author":"D Chen","year":"2023","unstructured":"Chen D, Liu X, Lu X, Tian J (2023) Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Front Pharmacol 14:1111991. https:\/\/doi.org\/10.3389\/fphar.2023.1111991","journal-title":"Front Pharmacol"},{"key":"1455_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112737","volume":"218","author":"V De Leo","year":"2022","unstructured":"De Leo V, Maurelli AM, Giotta L, Catucci L (2022) Liposomes containing nanoparticles: preparation and applications. Colloids Surf B Biointerfaces 218:112737. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112737","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1455_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpb.2023.09.014","volume":"192","author":"EK Silli","year":"2023","unstructured":"Silli EK, Li M, Shao Y et al (2023) Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. Eur J Pharm Biopharm 192:13\u201324. https:\/\/doi.org\/10.1016\/j.ejpb.2023.09.014","journal-title":"Eur J Pharm Biopharm"},{"key":"1455_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2022.12.013","volume":"157","author":"F Raza","year":"2023","unstructured":"Raza F, Evans L, Motallebi M et al (2023) Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomater 157:1\u201323. https:\/\/doi.org\/10.1016\/j.actbio.2022.12.013","journal-title":"Acta Biomater"},{"key":"1455_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"DE Large","year":"2021","unstructured":"Large DE, Abdelmessih RG, Fink EA, Auguste DT (2021) Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev 176:113851. https:\/\/doi.org\/10.1016\/j.addr.2021.113851","journal-title":"Adv Drug Deliv Rev"},{"key":"1455_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N et al (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 11:571. https:\/\/doi.org\/10.3390\/jpm11060571","journal-title":"J Pers Med"},{"key":"1455_CR17","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.3390\/ijms22126547","volume":"22","author":"L \u0160turm","year":"2021","unstructured":"\u0160turm L, Poklar Ulrih N (2021) Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols. Int J Mol Sci 22:6547. https:\/\/doi.org\/10.3390\/ijms22126547","journal-title":"Int J Mol Sci"},{"key":"1455_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F et al (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286. https:\/\/doi.org\/10.3389\/fphar.2015.00286","journal-title":"Front Pharmacol"},{"key":"1455_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/md17090487","volume":"17","author":"S Luthuli","year":"2019","unstructured":"Luthuli S, Wu S, Cheng Y et al (2019) Therapeutic effects of fucoidan: A review on recent studies. Mar Drugs 17:487. https:\/\/doi.org\/10.3390\/md17090487","journal-title":"Mar Drugs"},{"key":"1455_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/md21030183","volume":"21","author":"ASP Moreira","year":"2023","unstructured":"Moreira ASP, Gaspar D, Ferreira SS et al (2023) Water-soluble saccharina latissima polysaccharides and relation of their structural characteristics with in vitro immunostimulatory and hypocholesterolemic activities. Mar Drugs 21:183. https:\/\/doi.org\/10.3390\/md21030183","journal-title":"Mar Drugs"},{"key":"1455_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/md21050307","volume":"21","author":"E Turrini","year":"2023","unstructured":"Turrini E, Maffei F, Fimognari C (2023) Ten years of research on fucoidan and cancer: Focus on its antiangiogenic and antimetastatic effects. Mar Drugs 21:307. https:\/\/doi.org\/10.3390\/md21050307","journal-title":"Mar Drugs"},{"key":"1455_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12935-020-01233-8","volume":"20","author":"Y Lin","year":"2020","unstructured":"Lin Y, Qi X, Liu H et al (2020) The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations. Cancer Cell Int 20:154. https:\/\/doi.org\/10.1186\/s12935-020-01233-8","journal-title":"Cancer Cell Int"},{"key":"1455_CR23","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.3390\/molecules27186032","volume":"27","author":"J-O Jin","year":"2022","unstructured":"Jin J-O, Yadav D, Madhwani K et al (2022) Seaweeds in the oncology arena: Anti-cancer potential of fucoidan as a drug\u2014a review. Molecules 27:6032. https:\/\/doi.org\/10.3390\/molecules27186032","journal-title":"Molecules"},{"key":"1455_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104135","volume":"80","author":"M Li","year":"2023","unstructured":"Li M, Chen H, Peng D et al (2023) FU-coating pH-sensitive liposomes for improving the release of gemcitabine by endosome escape in pancreatic cancer cells. J Drug Deliv Sci Technol 80:104135. https:\/\/doi.org\/10.1016\/j.jddst.2022.104135","journal-title":"J Drug Deliv Sci Technol"},{"key":"1455_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104872","volume":"87","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Peng D, Li M et al (2023) Gemcitabine and Pin1 siRNA co-delivery with fucoidan-coated nano-liposomes for therapy of pancreatic cancer. J Drug Deliv Sci Technol 87:104872. https:\/\/doi.org\/10.1016\/j.jddst.2023.104872","journal-title":"J Drug Deliv Sci Technol"},{"key":"1455_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.algal.2018.01.002","volume":"30","author":"N Fl\u00f3rez-Fern\u00e1ndez","year":"2018","unstructured":"Fl\u00f3rez-Fern\u00e1ndez N, Torres MD, Gonz\u00e1lez-Mu\u00f1oz MJ, Dom\u00ednguez H (2018) Potential of intensification techniques for the extraction and depolymerization of fucoidan. Algal Res 30:128\u2013148. https:\/\/doi.org\/10.1016\/j.algal.2018.01.002","journal-title":"Algal Res"},{"key":"1455_CR27","first-page":"1","volume-title":"Liposome-Based Drug Delivery Systems","author":"B Xiang","year":"2017","unstructured":"Xiang B, Cao D-Y (2017) Preparation of drug liposomes by thin-film hydration and homogenization. In: Lu W-L, Qi X-R (eds) Liposome-Based Drug Delivery Systems. Springer, Berlin, Heidelberg, pp 1\u201311"},{"key":"1455_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0169-409X(99)00041-1","volume":"40","author":"A Nagayasu","year":"1999","unstructured":"Nagayasu A, Uchiyama K, Kiwada H (1999) The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev 40:75\u201387. https:\/\/doi.org\/10.1016\/S0169-409X(99)00041-1","journal-title":"Adv Drug Deliv Rev"},{"key":"1455_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijpharm.2011.10.056","volume":"422","author":"D Cosco","year":"2012","unstructured":"Cosco D, Paolino D, Cilurzo F et al (2012) Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. Int J Pharm 422:229\u2013237. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.056","journal-title":"Int J Pharm"},{"key":"1455_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/ijms22010457","volume":"22","author":"R Kola\u0161inac","year":"2021","unstructured":"Kola\u0161inac R, Bier D, Schmitt L et al (2021) Delivery of the radionuclide 131I using cationic fusogenic liposomes as nanocarriers. Int J Mol Sci 22:457. https:\/\/doi.org\/10.3390\/ijms22010457","journal-title":"Int J Mol Sci"},{"key":"1455_CR31","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.2147\/IJN.S34025","volume":"7","author":"C Federico","year":"2012","unstructured":"Federico C, Morittu VM, Britti D et al (2012) Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives. Int J Nanomedicine 7:5423\u20135436. https:\/\/doi.org\/10.2147\/IJN.S34025","journal-title":"Int J Nanomedicine"},{"key":"1455_CR32","unstructured":"Pham J, Ranjan A, Vishwanatha J (2021) Development and in vitro characterization of gemcitabine loaded nanoparticles for pancreatic cancer therapy. https:\/\/hdl.handle.net\/20.500.12503\/30476. Accessed 26 February 2024"},{"key":"1455_CR33","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1021\/acs.molpharmaceut.8b01284","volume":"16","author":"T Hassan","year":"2019","unstructured":"Hassan T, Jinho P, Hytham HG et al (2019) Development of liposomal gemcitabine with high drug loading capacity. Mol Pharm 16:2858\u20132871. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01284","journal-title":"Mol Pharm"},{"key":"1455_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/08982104.2010.550265","volume":"21","author":"M di Cagno","year":"2011","unstructured":"di Cagno M, Styskala J, Hlav\u00e1\u010d J et al (2011) Liposomal solubilization of new 3-hydroxy-quinolinone derivatives with promising anticancer activity: a screening method to identify maximum incorporation capacity. J Liposome Res 21:272\u2013278. https:\/\/doi.org\/10.3109\/08982104.2010.550265","journal-title":"J Liposome Res"},{"key":"1455_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106267","volume":"177","author":"AM Hols\u00e6ter","year":"2022","unstructured":"Hols\u00e6ter AM, Wizgird K, Karlsen I et al (2022) How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition\u2013A formulation screening study. Eur J Pharm Sci 177:106267. https:\/\/doi.org\/10.1016\/j.ejps.2022.106267","journal-title":"Eur J Pharm Sci"},{"key":"1455_CR36","doi-asserted-by":"publisher","unstructured":"Massing U, Ingebrigtsen S, Skalko-Basnet N, Hols\u00e6ter A (2017) Dual centrifugation - a novel \u201cin-vial\u201d liposome processing technique. IntechOpen, pp 3\u201328. https:\/\/doi.org\/10.5772\/intechopen.68523","DOI":"10.5772\/intechopen.68523"},{"key":"1455_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajps.2014.09.004","volume":"10","author":"J Li","year":"2015","unstructured":"Li J, Wang X, Zhang T et al (2015) A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 10:81\u201398. https:\/\/doi.org\/10.1016\/j.ajps.2014.09.004","journal-title":"Asian J Pharm Sci"},{"key":"1455_CR38","doi-asserted-by":"publisher","first-page":"20140459","DOI":"10.1098\/rsif.2014.0459","volume":"11","author":"N Monteiro","year":"2014","unstructured":"Monteiro N, Martins A, Reis RL, Neves NM (2014) Liposomes in tissue engineering and regenerative medicine. J R Soc Interface 11:20140459. https:\/\/doi.org\/10.1098\/rsif.2014.0459","journal-title":"J R Soc Interface"},{"issue":"1S","key":"1455_CR39","first-page":"30","volume":"8","author":"W Ari","year":"2019","unstructured":"Ari W, Rahma E, Thiara Eka F (2019) Effects of sonicator usage time on entrapment efficiency of liposome magnesium ascorbyl phosphate made by thin layer hydration method. Res J Pharm Biol Chem Sci 8(1S):30\u201336","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"1455_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/jfb13040186","volume":"13","author":"L-A Tziveleka","year":"2022","unstructured":"Tziveleka L-A, Pippa N, Ioannou E et al (2022) Development of ulvan-containing liposomes as antibacterial drug delivery platforms. J Funct Biomater 13:186. https:\/\/doi.org\/10.3390\/jfb13040186","journal-title":"J Funct Biomater"},{"key":"1455_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120504","volume":"600","author":"C Loira-Pastoriza","year":"2021","unstructured":"Loira-Pastoriza C, Vanvarenberg K, Ucakar B et al (2021) Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancer. Int J Pharm 600:120504. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120504","journal-title":"Int J Pharm"},{"key":"1455_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-819943-5.00002-6","volume-title":"Nanotoxicity","author":"K Kansara","year":"2020","unstructured":"Kansara K, Kumar A (2020) Chapter 2 - In vitro methods to assess the cellular toxicity of nanoparticles. In: Rajendran S, Mukherjee A, Nguyen TA et al (eds) Nanotoxicity. Elsevier, pp 21\u201340"},{"key":"1455_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jps.1063","volume":"90","author":"RB Campbell","year":"2001","unstructured":"Campbell RB, Balasubramanian SV, Straubinger RM (2001) Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. J Pharm Sci 90:1091\u20131105. https:\/\/doi.org\/10.1002\/jps.1063","journal-title":"J Pharm Sci"},{"key":"1455_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","volume":"14","author":"D Lombardo","year":"2022","unstructured":"Lombardo D, Kiselev MA (2022) Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics 14:543. https:\/\/doi.org\/10.3390\/pharmaceutics14030543","journal-title":"Pharmaceutics"},{"key":"1455_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0005-2736(01)00290-5","volume":"1512","author":"RB Campbell","year":"2001","unstructured":"Campbell RB, Balasubramanian SV, Straubinger RM (2001) Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochim Biophys Acta BBA Biomembr 1512:27\u201339. https:\/\/doi.org\/10.1016\/S0005-2736(01)00290-5","journal-title":"Biochim Biophys Acta BBA Biomembr"},{"key":"1455_CR46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.omtm.2020.07.015","volume":"18","author":"C Liu","year":"2020","unstructured":"Liu C, Zhang L, Zhu W et al (2020) Barriers and strategies of cationic liposomes for cancer gene therapy. Mol Ther Methods Clin Dev 18:751\u2013764. https:\/\/doi.org\/10.1016\/j.omtm.2020.07.015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1455_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/nano11030597","volume":"11","author":"S Habib","year":"2021","unstructured":"Habib S, Singh M (2021) Recent advances in lipid-based nanosystems for gemcitabine and gemcitabine-combination therapy. Nanomaterials 11:597. https:\/\/doi.org\/10.3390\/nano11030597","journal-title":"Nanomaterials"},{"key":"1455_CR48","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13402-013-0146-4","volume":"36","author":"A-L Papa","year":"2013","unstructured":"Papa A-L, Sidiqui A, Balasubramanian SUA et al (2013) PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic. Cell Oncol 36:449\u2013457. https:\/\/doi.org\/10.1007\/s13402-013-0146-4","journal-title":"Cell Oncol"},{"key":"1455_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.116837","volume":"249","author":"M Jafari","year":"2020","unstructured":"Jafari M, Sriram V, Xu Z et al (2020) Fucoidan-doxorubicin nanoparticles targeting p-selectin for effective breast cancer therapy. Carbohydr Polym 249:116837. https:\/\/doi.org\/10.1016\/j.carbpol.2020.116837","journal-title":"Carbohydr Polym"},{"key":"1455_CR50","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1002\/jps.24111","volume":"103","author":"J-Y Lee","year":"2014","unstructured":"Lee J-Y, Yang H, Yoon I-S et al (2014) Nanocomplexes based on amphiphilic hyaluronic acid derivative and polyethylene glycol-lipid for ginsenoside Rg3 delivery. J Pharm Sci 103:3254\u20133262. https:\/\/doi.org\/10.1002\/jps.24111","journal-title":"J Pharm Sci"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-024-01455-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01455-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T21:06:51Z","timestamp":1733605611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-024-01455-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,18]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s10637-024-01455-x","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,18]]},"assertion":[{"value":"1 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}